X0609 4 2026-01-22 0 0001860657 Allarity Therapeutics, Inc. ALLR 0001975028 Graff Jeremy R. false C/O ALLARITY THERAPEUTICS, INC. 123 E TARPON AVE TARPON SPRINGS FL 34689 0 1 0 0 See Remarks 0 Common Stock 2026-01-22 4 M 0 48147 A 73028 D Common Stock 2026-01-22 4 F 0 17814 1.18 D 55214 D Common Stock 2026-09-30 4 M 0 39494 A 94708 D Common Stock 2026-09-30 4 F 0 14613 0.97 D 80095 D Restricted Stock Units 2026-01-22 4 M 0 48147 0 D Common Stock 48147 175283 D Restricted Stock Units 2026-09-30 4 M 0 39494 0 D Common Stock 39494 269122 D Restricted stock units convert into common stock on a one-for-one basis. On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date. Represents shares withheld by the Issuer to satisfy tax withholding obligations arising upon the vesting and settlement of restricted stock units. The shares were withheld based on the fair market value of the Issuer's common stock on the applicable vesting date. The amount reported in column 9 reflects 175,283 restricted stock units outstanding following the January 22, 2026 settlement, plus 133,333 restricted stock units granted on January 28, 2026 and previously reported, less 39,494 restricted stock units settled on September 30, 2026. The 381,644 amount previously reported in column 5 of Table I of the Reporting Person's Form 4/A filed April 30, 2026 combined issued shares of common stock and unvested restricted stock units and did not reflect the 17,814 shares withheld on January 22, 2026. This Form 4 reports issued shares of common stock in Table I and unvested restricted stock units separately in Table II. After giving effect to the January 22, 2026 vesting and withholding and the January 28, 2026 restricted stock unit grant, the correct balances were 55,214 shares of common stock and 308,616 restricted stock units. President and Chief Development Officer /s/ Jeremy R. Graff 2026-10-09